TipRanks
Advertisement
Advertisement

GUTS Stock Latest News

Fractyl Health Inc trading halted, news pending
The FlyFractyl Health Inc trading halted, news pending
11h ago
GUTS
Shareholders Sue Fractyl (GUTS) Over Weight Loss Drug Claims
PremiumMarket News
Shareholders Sue Fractyl (GUTS) Over Weight Loss Drug Claims
2d ago
GUTS
Fractyl Health Implements One-for-Twelve Reverse Stock Split
PremiumCompany Announcements
Fractyl Health Implements One-for-Twelve Reverse Stock Split
2d ago
8K
GUTS
Fractyl Health Stockholders Approve Reverse Stock Split Plan
PremiumCompany Announcements
Fractyl Health Stockholders Approve Reverse Stock Split Plan
9d ago
8K
GUTS
Fractyl Health Faces Nasdaq Delisting, Plans Reverse Split
PremiumCompany Announcements
Fractyl Health Faces Nasdaq Delisting, Plans Reverse Split
22d ago
8K
GUTS
Fractyl Health Lawsuit Alleges Revita Disclosures Misled Investors Before GUTS Stock Drop
PremiumClass ActionFractyl Health Lawsuit Alleges Revita Disclosures Misled Investors Before GUTS Stock Drop
30d ago
GUTS
Fractyl Health Lawsuit Alleges Revita Disclosures Led to Investor Losses After GUTS Stock Drop 
Premium
Class Action
Fractyl Health Lawsuit Alleges Revita Disclosures Led to Investor Losses After GUTS Stock Drop 
1M ago
GUTS
Fractyl Health Earnings Call Signals Promise Amid Risks
Premium
Company Announcements
Fractyl Health Earnings Call Signals Promise Amid Risks
1M ago
GUTS
Fractyl Health reports Q2 EPS (16c), consensus (14c)
PremiumThe Fly
Fractyl Health reports Q2 EPS (16c), consensus (14c)
2M ago
GUTS
GUTS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
GUTS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
GUTS
Hold Rating Reaffirmed as Revita Data Show Promise but Risks and Valuation Keep Price Target Unchanged at $2
PremiumRatings
Hold Rating Reaffirmed as Revita Data Show Promise but Risks and Valuation Keep Price Target Unchanged at $2
3M ago
GUTS
Fractyl Health reports results from REMAIN-1 Midpoint Cohort
PremiumThe Fly
Fractyl Health reports results from REMAIN-1 Midpoint Cohort
3M ago
GUTS
Craig-Hallum bullish on Fractyl Health, initiates with a Buy
PremiumThe FlyCraig-Hallum bullish on Fractyl Health, initiates with a Buy
3M ago
GUTS
Fractyl Health initiated with a Buy at Craig-Hallum
Premium
The Fly
Fractyl Health initiated with a Buy at Craig-Hallum
3M ago
GUTS
Fractyl Health Stockholders Back Board and Auditor at Meeting
Premium
Company Announcements
Fractyl Health Stockholders Back Board and Auditor at Meeting
4M ago
8K
GUTS
Analyst Reiterates Buy on Fractyl Health as New Revita Data De-Risk Durability; $8 Price Target Maintained
PremiumRatings
Analyst Reiterates Buy on Fractyl Health as New Revita Data De-Risk Durability; $8 Price Target Maintained
4M ago
GUTS
Fractyl Health Highlights One-Year Revita Obesity Results
PremiumCompany Announcements
Fractyl Health Highlights One-Year Revita Obesity Results
4M ago
8K
GUTS
Fractyl Health’s Pivotal Year: Inside the Earnings Call
PremiumCompany Announcements
Fractyl Health’s Pivotal Year: Inside the Earnings Call
5M ago
GUTS
Fractyl Health reports Q1 EPS 6c, consensus (16c)
PremiumThe Fly
Fractyl Health reports Q1 EPS 6c, consensus (16c)
5M ago
GUTS
Fractyl Health Advances RJVA-001 Gene Therapy Trial
PremiumCompany AnnouncementsFractyl Health Advances RJVA-001 Gene Therapy Trial
5M ago
8K
GUTS
Reiterated Buy on Strong Risk‑Reward Ahead of REMAIN‑1 Pivotal Data; $8 Price Target Unchanged
Premium
Ratings
Reiterated Buy on Strong Risk‑Reward Ahead of REMAIN‑1 Pivotal Data; $8 Price Target Unchanged
5M ago
GUTS
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
6M ago
GUTS
SMMT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >